Krzysztof Wilk

Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2)

Linda C. Giudice, Sawsan As‐Sanie, Juan Camilo Arjona Ferreira et al. · The Lancet · 2022 · 138 citations · Full text

Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone–antagonist: a randomized clinical trial

Jacques Donnez, Hugh S. Taylor, Robert N. Taylor et al. · Fertility and Sterility · 2020 · 105 citations · Full text

Randomized Clinical Trial, Hormonal Contraceptive, Pain Medicine +8

Prediction of Spontaneous Puberty in Turner Syndrome Based on Mid-Childhood Gonadotropin Concentrations, Karyotype, and Ovary Visualization: A Longitudinal Study

Magdalena Hankus, Kamil Sołtysik, Kamila Szeliga et al. · Hormone Research in Paediatrics · 2017 · 36 citations

Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study

Christian M. Becker, Neil P. Johnson, Sawsan As‐Sanie et al. · Human Reproduction · 2024 · 36 citations · Full text

Mechanical, Chemical, and Processing Properties of Specimens Manufactured from Poly-Ether-Ether-Ketone (PEEK) Using 3D Printing

Maciej Mrówka, Tomasz Machoczek, P. Jureczko et al. · Materials · 2021 · 30 citations · Full text